Interview – Wem nützt die präoperative MRT wirklich?
暂无分享,去创建一个
[1] L. Tabár,et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.
[2] Philippe Autier,et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database , 2011, BMJ : British Medical Journal.
[3] J. Hanley. Measuring mortality reductions in cancer screening trials. , 2011, Epidemiologic reviews.
[4] K. Aben,et al. Declined Guideline Adherence in Older Breast Cancer Patients: A Population‐Based Study in The Netherlands , 2011, The breast journal.
[5] Marvin Zelen,et al. Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.
[6] Guangyu Liu,et al. Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. , 2009, Critical reviews in oncology/hematology.
[7] D. Schopper,et al. How effective are breast cancer screening programmes by mammography? Review of the current evidence. , 2009, European journal of cancer.
[8] M Kalder,et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] J. Forbes,et al. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Winer,et al. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] G. Vlastos,et al. Older female cancer patients: importance, causes, and consequences of undertreatment. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Micciolo,et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. , 2006, Critical reviews in oncology/hematology.
[13] E. Elkin,et al. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Goodwin,et al. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Crowley,et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] G. Hortobagyi,et al. Breast cancer treatment guidelines in older women. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Schraub,et al. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] R. Paridaens,et al. Taxanes in elderly breast cancer patients. , 2004, Cancer treatment reviews.
[19] G. Vlastos,et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Hendriks,et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review , 2003, The Lancet.
[21] Xianglin L. Du,et al. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] L. Tabár,et al. The mammographic screening trials: Commentary on the recent work by Olsen and Gøtzsche , 2002, Journal of surgical oncology.
[23] A. Miller. Screening for breast cancer with mammography , 2001, The Lancet.
[24] G. Hortobagyi,et al. Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] F. Cavalli,et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. Elledge,et al. Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.
[27] C. Coltman,et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.